TW204343B - - Google Patents
Download PDFInfo
- Publication number
- TW204343B TW204343B TW081104131A TW81104131A TW204343B TW 204343 B TW204343 B TW 204343B TW 081104131 A TW081104131 A TW 081104131A TW 81104131 A TW81104131 A TW 81104131A TW 204343 B TW204343 B TW 204343B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- solvent
- compound
- standard
- page
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15772591 | 1991-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW204343B true TW204343B (de) | 1993-04-21 |
Family
ID=15656005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW081104131A TW204343B (de) | 1991-05-31 | 1992-05-27 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5225422A (de) |
EP (1) | EP0516069B1 (de) |
JP (1) | JPH05239004A (de) |
KR (1) | KR920021534A (de) |
AT (1) | ATE137223T1 (de) |
AU (1) | AU643140B2 (de) |
CA (1) | CA2069667A1 (de) |
DE (1) | DE69210091T2 (de) |
DK (1) | DK0516069T3 (de) |
ES (1) | ES2086579T3 (de) |
GR (1) | GR3020050T3 (de) |
MX (1) | MX9202612A (de) |
TW (1) | TW204343B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407124B1 (en) | 1998-06-18 | 2002-06-18 | Bristol-Myers Squibb Company | Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
DE10029077A1 (de) * | 2000-06-13 | 2001-12-20 | Bayer Ag | Thiazolylsubstituierte Heterocyclen |
DE10257785A1 (de) * | 2002-12-11 | 2004-07-01 | Bayer Healthcare Ag | Isophthalsäurederivate |
AU2011226942B2 (en) * | 2004-11-22 | 2012-06-28 | Eli Lilly And Company | Potentiators of glutamate receptors |
WO2006057870A1 (en) * | 2004-11-22 | 2006-06-01 | Eli Lilly And Company | Potentiators of glutamate receptors |
US20060235028A1 (en) * | 2005-04-14 | 2006-10-19 | Li James J | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
BRPI0610506A2 (pt) | 2005-04-20 | 2010-06-29 | Johnson & Johnson | moduladores de trombina de n-óxidos de piridina fluorados e processo para n-oxidação de heteroarilas contendo nitrogênio |
TW201006801A (en) | 2008-07-18 | 2010-02-16 | Lilly Co Eli | Imidazole carboxamides |
US9321727B2 (en) * | 2011-06-10 | 2016-04-26 | Hoffmann-La Roche Inc. | Pyridine derivatives as agonists of the CB2 receptor |
US11497752B2 (en) * | 2018-01-30 | 2022-11-15 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666928A (en) * | 1984-08-30 | 1987-05-19 | Merck Frosst Canada, Ind. | Propylphenoxy pyridine carboxylates as leukotriene antagonists |
US4672066A (en) * | 1985-04-22 | 1987-06-09 | Hoffmann-La Roche Inc. | Derivatives of 4-acetyl-3-hydroxy-2-alkyl-phenoxycarboxylic acids |
US4663332A (en) * | 1985-10-10 | 1987-05-05 | Hoffman-La Roche Inc. | 5-substituted N-alkylated tetrazoles |
CA1315279C (en) * | 1987-01-12 | 1993-03-30 | Nancy Grace Bollinger | Anti-inflammatory agents |
JPS6429363A (en) * | 1987-07-23 | 1989-01-31 | Yoshitomi Pharmaceutical | Heterocyclic derivative |
-
1992
- 1992-05-27 TW TW081104131A patent/TW204343B/zh active
- 1992-05-27 AU AU17193/92A patent/AU643140B2/en not_active Ceased
- 1992-05-27 EP EP92108916A patent/EP0516069B1/de not_active Expired - Lifetime
- 1992-05-27 ES ES92108916T patent/ES2086579T3/es not_active Expired - Lifetime
- 1992-05-27 CA CA002069667A patent/CA2069667A1/en not_active Abandoned
- 1992-05-27 DK DK92108916.5T patent/DK0516069T3/da active
- 1992-05-27 AT AT92108916T patent/ATE137223T1/de not_active IP Right Cessation
- 1992-05-27 DE DE69210091T patent/DE69210091T2/de not_active Expired - Fee Related
- 1992-05-28 JP JP4164065A patent/JPH05239004A/ja active Pending
- 1992-05-30 KR KR1019920009440A patent/KR920021534A/ko not_active Application Discontinuation
- 1992-06-01 MX MX9202612A patent/MX9202612A/es not_active IP Right Cessation
- 1992-06-01 US US07/891,256 patent/US5225422A/en not_active Expired - Fee Related
-
1996
- 1996-05-27 GR GR960401413T patent/GR3020050T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2069667A1 (en) | 1992-12-01 |
AU1719392A (en) | 1993-03-11 |
DE69210091D1 (de) | 1996-05-30 |
EP0516069A1 (de) | 1992-12-02 |
DK0516069T3 (da) | 1996-05-13 |
ES2086579T3 (es) | 1996-07-01 |
GR3020050T3 (en) | 1996-08-31 |
AU643140B2 (en) | 1993-11-04 |
US5225422A (en) | 1993-07-06 |
DE69210091T2 (de) | 1996-10-02 |
ATE137223T1 (de) | 1996-05-15 |
MX9202612A (es) | 1992-11-01 |
JPH05239004A (ja) | 1993-09-17 |
KR920021534A (ko) | 1992-12-18 |
EP0516069B1 (de) | 1996-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11059805B2 (en) | Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof | |
US9604980B2 (en) | Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors | |
ES2614355T3 (es) | Derivados de glicina N-sustituida con piridazin-diona como inhibidores de HIF hidoxilasas | |
TW304197B (de) | ||
CA3095019C (en) | Substituted pyridine derivatives and compositions thereof useful as inhibitors of histone demethylases | |
TW519538B (en) | Heterocyclic compounds and medical use thereof | |
TW204343B (de) | ||
CN106029659B (zh) | 谷氨酰胺酶抑制剂 | |
AU2011205302B2 (en) | Voltage-gated sodium channel blockers | |
JP7495395B2 (ja) | 抗菌性化合物 | |
WO2007010965A1 (ja) | Pgd2受容体アンタゴニスト活性を有するアザインドール酸誘導体 | |
JP6456392B2 (ja) | 3−アリール−5−置換イソキノリン−1−オン化合物及びその治療的使用 | |
PT100041B (pt) | Processo para a preparacao de derivados de indol e de composicoes farmaceuticas que os contem | |
TW200815412A (en) | A pharmaceutical combination comprising 3-or 4-monosubstituted phenol and thiophenol derivatives | |
JP2013507371A (ja) | Gタンパク質共役受容体88の調節因子 | |
ITMI20002202A1 (it) | Farmaci per le malattie a base infiammatoria | |
TW201623264A (zh) | 作為電位閘控鈉通道調節劑之磺胺化合物 | |
EP3397617A1 (de) | Histondemethylaseinhibitoren | |
JPH07503248A (ja) | 複素三環式誘導体、それらの製造法およびそれらを含有する医薬組成物 | |
US10995072B2 (en) | Inhibitors of protease-activated receptor-2 | |
AU2012279091A1 (en) | Voltage-gated sodium channel blockers | |
US11787768B2 (en) | Tetrahydroquinoline-based bromodomain inhibitors | |
TW593294B (en) | Polycyclic thiazole systems having anorectic activity, processes for their preparation and pharmaceutical composition comprising these compounds | |
CN117242061A (zh) | 用于治疗艰难梭菌的二氮杂卓衍生物 | |
WO2001034152A1 (fr) | Gouttes nasales contenant des derives de pyridazine condenses |